OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

MESSAGE FROM THE CHAIR AND CHIEF EXECUTIVE
WHO WE ARE
ALLERGY IN THE UK
OUR VISION AND MISSION
OUR VALUES
FUNDRAISING
SUPERSTARS
SERVICESTO SUPPORT THE ALLERGIC COMMUNITY 10
CAMPAIGNS
AND COMMUNICATIONS
16
ONLINE REACH 19
COLLABORATIONS
AND LOBBYING
20
CLINICAL AND RESEARCH 21
CONNECTIONS
AND INFLUENCE
24
CORPORATE PARTNERS 29
STRUCTURE, GOVERNANCE AND MANAGEMENT 30
CHALLENGES AND RISKS 32
FINANCIAL REVIEW 34

Unrestricted Designated Restricted Total Total
Funds Funds Funds 2021 2020
Notes
Income
Donations
and Legacies
199,425 73,809 273,234 44,674
Other Government
Grants
85,595 85.595
Income From charitable activities 9,620 9,620 20,226
Income From trading activities:
Seal oFapproval 338,326 338,326 510,895
Renewals 621,303 621,303 589,589
Allergy Friendly Products 61,525 61,525 62,950
Agergy Awareness Scheme (117) (117) 4,850
Alerts 4,325 4,325 2,608
Corporate partners 285,392 51,800 337,192 285,116
Fundraising
events
19,453 19,453 38,341
Investment
Income
8,770 8,770 6,262
Total Incomin
Resources
8 1,633,617 125,609 1,759,226 1,565,512
EXPENDITURE
Cost oFraising Funds:
Voluntary
income
157,954 5,263 163,217 241,757
Commercial
trading
operations 495,175 495,175 826,900
Expenditure
on charitable activities
564,005 156,531 49,290 769,826 830,715
Total resources ex ended 1,217,134 161,794 49,290 1,428,218 1,899,372
Net income l(expenditure)
Forthe year 10 416,483 (161,794) 76,319 331,008 (333,860)
Reconciliation ofFunds
Total funds brought
Forward
91,665 737,095 9,600 838,360 1,172,220
Transfer between
Funds
21 (219,146) 219,146
Tot
Ifunds carried
orwar
289,002 794,447 85,919 1,169,368 838,360

2021 2020
Notes E
Fixed Assets
Intangible Assets 15 126,851 145,755
Tangible Assets 15 22,695 30,260
Investments 16 12 12
149,558 176,027
Current Assets
Debtors 17 252,335 420,274
Short Term Investments 18 853,098 652,852
Stock 600
Cash at Bank and in Hand 515,702 234,033
1,621,735 1,307,159
Creditors: Amounts Falling due
within one year 19 601,925 644,826
Net Current Assets 1,019,810 662,333
Total Assets Less Current Liabilities 1,169,368 838,360
Net assets 1,169,368 838,360
Funds
Restricted 20 85,919 9,600
Unrestricted 21 1,083,450 828,760
Total funds 1,169,368 838,360

Notes Group
2021 2020
Cash inAow/(outAow)
from operating
activities
24 473,146 (82,671)
Cash inAow From investing
activities
Interest income 8,770 6,262
Cash used in investing
activities
Purchase ofAxed assets (38,311)
Increase in term deposit accounts (200,246) (52,852)
Net cash (outAows) from investing
activites
(191,476) (84,901)
Increase/(decrease)
in cash and cash equivalents
in the year 281,670 (167,572)
Cash and cash equivalents
at 1 April 2020
234,033 401,605
Total cash and cash equivalents
at 31March 2021
515,702 234,033
Cash and cash equivalents
consists oF:
Cash at bank and in hand 515,702 234,033
Cash and cash equivalents
at31March 2021
515,702 234,033

The consolidated
statement of
The consolidated
statement of
The consolidated
statement of
Financial activities includes the results oFAllergy Research Limited Financial activities includes the results oFAllergy Research Limited Financial activities includes the results oFAllergy Research Limited one ofthe Charity's wholly
owned subsidiaries which operates the trade activities oFthe group including the Seal oFApproval, training, Allergy Aware Scheme
and an allergy alert service.
The summary Financial performance oFthe Charity alone is:
2021 2020
Income 396,641 109,251
Service charge From asubsidiary company 300,000 300,000
GiFt aid from a subsidiary
company
851,332 660,713
1,547,973 1,069,964
Expenditure on Fund raising 86,932 52,764
Expenditure on trading 228,808 355,952
Expenditure on charitable activities 739,430 862,241
1,055,171 1,270,957
Net income 492,802 (200,993)
Total Funds brought Forward 950,046 1,151,039
Total Funds carried Forward 1,442,848 950,046
Income From donation
and legacies
2021 2020
Gifts 108,234 44,674
Legacies 165,000
273,234 44,674

2021 2020
Government Grants - Coronavirus Job Retention Scheme 85,595
85,595
The income From government grants was E85,595unrestricted (2020:Enil) and Enil restricted (2020:Enil).
Income From charitable activities
2021 2020
Income from translation cards 326 19,230
Fees received 9,294 92
AFI1(late marketing 904
9,620 20,226

2021 2020
Turnover 1,362,554 1,456,008
Cost ofsales and administration costs (511,253) (795,548)
Interest income 31 253
Net profit 851,332 660,713
Amount gift aided to the charity (851,332) (660,713)
Retained
in subsidiary
The assets and liabilities oFthe subsidiary were:
Fixed assets 3,695 4,467
Current assets 614,987 566,463
Current liabilities (597,497) (549,747)
Total net assets 21,186 21,183
Share capital
ProFit and loss reserve 21,184 21,181
21,186 21,183

Turnover
2021 2020
Turnover split geographically:
United Kingdom 936,876 565,389
The Rest ofthe World 813,580 991,123
1,750,456 1,556,512

2021 2020
This is stated after charging: E E
Operating leases - office 71,214 75,738
Operating leases -equipment 10,560 9,789
Auditors fees 10,350 11.794
11. Analysis ofstaff costs, Trustees expenses and the costofkey management personnel
2021 2020
E E
Salaries and wages 633,171 757,939
Redundancy costs 18,032
Social security costs 58,144 69,584
Pension costs 19,267 23,627
Number oF employees' with emoluments, as defined For tax purposes, that amounted to over E60,000 in the year.
2021 2020
E70,000to F79,999 1
E60,000to E69,999 1
The average monthly head count was 23 stafF(2020 = 28)and the average number oFFull time equivalent employees
(FTE)during the year were as follows:
2021 2020
Number Number
Charitable activities 13 15
Generating funds 6 9

2021 2020
Fees payable to the charity's auditors for the audit oFthe charity's annual accounts 6,135 6,392
Fees payable to the charity's auditors Forother services:
Audit oFthe charity's subsidiaries 4,215 2,901
Other services 2,500
10,350 11,794

Intangib le
Axed assets
Group Charity
2021 2020 2021 2020
E f.
Website and development costs
Cost
At 1 April 2020 233,905 215,072 229,349 210,516
Additions 18,833 18,833
Disposals
At 31March 2021 233,905 233,905 229,349 229,349
Amortisation
At 1 April 2020 88,150 63,647 86,797 62,749
Charge Forthe year 18,904 24,503 18,449 24,048
On disposals
At 31March 2021 107,055 88,150 105,245 86,797
Net book value
At 31 March 2021 126,850 145,755 124,104 142,552
At 31March 2020 145,755 151,425 142,552 147,767
Tangible Fixed assets
Group Charity
2021 2020 2021 2020
f. f.
0%ceFurniture and equipment
Cost
At 1 April 2020 135,574 116,095 120,517 101,038
Additions 19,479 19,479
Disposals
At 31 March 2021 135,574 135,574 120,517 120,517
Depreciation
At 1 April 2020 105,313 97,910 91,521 84,482
Charge Forthe year 7,565 7,403 7,249 7,039
On disposals
At 31 March 2021 112,878 105,313 98,770 91,521
Net book value
At 31 March 2021 22,695 30,261 21,747 28,996
At 31 March 2020 30,260 18,185 28,996 16,556

21. Unrestricted
Funds - 2020/2021
As at 1stApril
2020
Surplus/Deficit
2020/21
For Expenditure Transfers As at31stMarch
2021
E E E E
General free reserve 70,482 416,483 (219,146) 267,819
Designated:
Fixed assets reserve 28,996 (7,250) 21,746
Allergy
UKnurses project
186,616 (108,618) (77,998)
CRM/Digital
Media reserve
50,000 (43,810) 15,000 21,190
Contingency
Fund
466,220 466,220
Fundraising
reserve
5,263 (5,263) 50,000 50,000
Board Project reserve (4,103) 4,103
Shout Out to Allergy reserve 50,000 50,000
Resource Building reserve 100,291 100,291
Project Delivery reserve 75,000 75,000
ITreserve 10,000 10,000
Total Charity Reserves 807,577 416,483 (161,794) 1,062,266
Allergy Research Ltd 21,183 21,183
Total Group Reserves 828,760 416,483 (161,794) 1,083,449
Unrestricted Funds —2019/2020
As at 1stApril
2019
Surplus/Deficit
2019/20
For Expenditure Transfers As at31stMarch
2020
E E E f.
General Free reserve 85,227 (174,293) 159,548 70,482
Designated:
Fixed assets reserve 16,556 12,440 28,996
Allergy
UK nurses project
212,260 (46,686) 21,042 186,616
CRM/Digital Media reserve 200,000 (150,000) 50,000
Contingency Fund 600,694 (134,474) 466,220
Fundraising reserve (86,181) 91,444 5,263
Total Charity Reserves 1,114,737 (174,293) (132,867) 807,577
Allergy Research Ltd 21,183 21,183
Total Group Reserves 1,135,920 (174,293) (132,867) 828,760

As at 31M arch 2021
General Fixed Contingency Fd.
Fundraising
Shout Out
to Allergy
Resource
Suilding
project
Delivery
IT Restricted Total
Reserves Assets Fund Reserve Reserve Reserve Reserve Reserve Reserve Funds Funds
Tangible Fixed assets 127,812 21,746 149,558
Current assets 743,350 466,220 21,190 50,000 50,000 100,291 75,000 10,000 85,919 1,601,969
Current liabilities (582,160) (582,160)
Net assets at 31
March 2021
289,002 21,746 466,220 21,190 50,000 50,000 100,291 75,000 10,000 85,919 1,169,368

As at31March 202 0
General Fixed Contingency Nurses CRM Fundraising Restricted Total
Reserves Assets Fund Reserve Reserve Reserve Funds Funds
E E E E E
Tangible fixed assets 147,031 28,996 176,027
Current assets 589,460 466,220 186,616 50,000 5,263 9,600 1,307,159
Current
liabilities
(644,826) (644,826)
Net assets at 31
March 2020
91,665 28,996 466,220 186,616 50,000 5,263 9,600 838,360